A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD
- PMID: 33973269
- DOI: 10.1002/hep.31897
A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD
Abstract
Background and aims: Animal models of human disease are a key component of translational hepatology research, yet there is no consensus on which model is optimal for NAFLD.
Approach and results: We generated a database of 3,920 rodent models of NAFLD. Study designs were highly heterogeneous, and therefore, few models had been cited more than once. Analysis of genetic models supported the current evidence for the role of adipose dysfunction and suggested a role for innate immunity in the progression of NAFLD. We identified that high-fat, high-fructose diets most closely recapitulate the human phenotype of NAFLD. There was substantial variability in the nomenclature of animal models: a consensus on terminology of specialist diets is needed. More broadly, this analysis demonstrates the variability in preclinical study design, which has wider implications for the reproducibility of in vivo experiments both in the field of hepatology and beyond.
Conclusions: This systematic analysis provides a framework for phenotypic assessment of NAFLD models and highlights the need for increased standardization and replication.
© 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Similar articles
-
Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.Am J Physiol Endocrinol Metab. 2016 Mar 15;310(6):E418-39. doi: 10.1152/ajpendo.00319.2015. Epub 2015 Dec 15. Am J Physiol Endocrinol Metab. 2016. PMID: 26670487 Free PMC article.
-
Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.J Transl Med. 2019 Apr 3;17(1):110. doi: 10.1186/s12967-019-1854-y. J Transl Med. 2019. PMID: 30943987 Free PMC article.
-
Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats.Lipids Health Dis. 2013 Sep 18;12:136. doi: 10.1186/1476-511X-12-136. Lipids Health Dis. 2013. PMID: 24044579 Free PMC article.
-
Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol.Cells. 2021 Jul 16;10(7):1805. doi: 10.3390/cells10071805. Cells. 2021. PMID: 34359974 Free PMC article. Review.
-
Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights.Gene Expr. 2018 Mar 21;18(1):5-17. doi: 10.3727/105221617X15093707969658. Epub 2017 Nov 2. Gene Expr. 2018. PMID: 29096730 Free PMC article. Review.
Cited by
-
Leukotriene B4 receptor 1 (BLT1) does not mediate disease progression in a mouse model of liver fibrosis.Biochem J. 2023 Nov 28;481(3):177-90. doi: 10.1042/BCJ20230422. Online ahead of print. Biochem J. 2023. PMID: 38014500 Free PMC article.
-
The LIDPAD Mouse Model Captures the Multisystem Interactions and Extrahepatic Complications in MASLD.Adv Sci (Weinh). 2024 Sep;11(35):e2404326. doi: 10.1002/advs.202404326. Epub 2024 Jul 1. Adv Sci (Weinh). 2024. PMID: 38952069 Free PMC article.
-
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).Nat Metab. 2024 Jun;6(6):1178-1196. doi: 10.1038/s42255-024-01043-6. Epub 2024 Jun 12. Nat Metab. 2024. PMID: 38867022 Free PMC article.
-
Sulforaphane Ameliorates Nonalcoholic Fatty Liver Disease Induced by High-Fat and High-Fructose Diet via LPS/TLR4 in the Gut-Liver Axis.Nutrients. 2023 Feb 1;15(3):743. doi: 10.3390/nu15030743. Nutrients. 2023. PMID: 36771448 Free PMC article.
-
The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway.Acta Pharm Sin B. 2023 Mar;13(3):1071-1092. doi: 10.1016/j.apsb.2022.12.006. Epub 2022 Dec 12. Acta Pharm Sin B. 2023. PMID: 36970206 Free PMC article.
References
-
- Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med 2017;377:2063-2072.
-
- Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2015;149:389-397.e10.
-
- Paik JM, Golabi P, Younossi Y, Srishord M, Mishra A, Younossi ZM. The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007-2017. Hepatol Commun 2020;4:1769-1780.
-
- Liu Z, Zhang Y, Graham S, Wang X, Cai D, Huang M, et al. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. J Hepatol 2020;73:263-276.
-
- Eslam M, Sanyal AJ, George J, Sanyal A, Neuschwander-Tetri B, Tiribelli C, et al. International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020;158:1999-2014.e1.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical